
- Volume 0 0
HRT and Alzheimer's Disease
The bad news is that hormone replacement therapy (HRT) may increase the likelihood of breast cancer in postmenopausal women. The good news, according to the results of a study published in the Journal of the American Medical Association (November 6, 2002), is that women who have taken HRT for at least 10 years are 2.5 times less likely to develop Alzheimer?s disease than non-HRT women.
The following are 2 other key points from this study: First, there was no benefit unless HRT had been begun several years before the onset of mental decline. Second, vitamin and calcium supplements had no effect on Alzheimer?s disease risk.
Articles in this issue
about 23 years ago
Pharmacist Shares Liability for Home Care Mishapabout 23 years ago
Taking Stock of the Family Medicine Cabinetabout 23 years ago
Recognizing Depression and the "Blues": A Pharmacist's Guideabout 23 years ago
Nurse Diversion in Health Facilities?Part IIabout 23 years ago
What Older Americans Need to Know About Alzheimer's Diseaseabout 23 years ago
Preparing for E-Prescribingabout 23 years ago
Ankylosing Spondylitisabout 23 years ago
Alarming Numbersabout 23 years ago
"Magic Bracelet"about 23 years ago
It May Not Be Carpal TunnelNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.












































































































































































































